• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New Academy gives Irish researchers a voice in policy making

New Academy gives Irish researchers a voice in policy making

February 14, 2012
CenterWatch Staff

The European Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn, has launched a new Academy to bring together Ireland's leading medical researchers to promote excellence in biomedical research, with the ultimate aim of improving the health of the population.

The Irish Academy of Medical Sciences (IAMS) will draw on the knowledge of Ireland's top medical scientists to provide an independent resource of expertise on complex issued related to medical science and ethics to ensure a coherent and integrated policy on health research at a national and international level.

The Royal College of Surgeons in Ireland (RCSI) academics Professor Orla Hardiman, Professor Brian Harvey, Professor Elaine Kay, Professor Gerry McElvaney and Professor Jochen Prehn are among the founding Fellows of the Academy.

Until now, Ireland was one of the few European countries with no established body to represent its medical researchers in this way. IAMS will allow Ireland to actively participate in medical sciences interchanges at the European level. The Academy will partner with state agencies and industry as an independent resource of expertise in medical science and healthcare.

"I welcome the formation of the new Academy, which harnesses the significant expertise that already exists within Irish academic medicine,” said Commissioner Geoghegan-Quinn. “Excellence in research ultimately leads to excellent care for patients. The strategic partnerships that will arise from the establishment of the Academy will contribute to building a knowledge-based economy, sustainable employment opportunities for Irish graduates and the overall improvement of Irish society and its healthcare system. I congratulate the founding Council of IAMS for this important initiative, which I am confident will ensure Ireland's position at the forefront of biomedical research into the future."

To coincide with the launch, the Academy published its first position paper on the future direction for biomedical research in Ireland. Among the issues highlighted is the importance of sustainable funding for biomedical research.

"While the level of investment in biomedical research in Ireland increased substantially during the boom years, it is essential that this momentum be maintained,” said Professor Dermot Kelleher, Honorary President, Irish Academy of Medical Sciences. “In terms of developing the key industry relationships for the knowledge economy, it is critical that the infrastructure in our teaching hospitals is seen as a source of real academic strength in terms of expertise and capacity in clinical research."

He continued, "Investing in publicly-funded biomedical research, and in particular clinically-based research, will lead to significant economic benefit, job creation, added value to the knowledge economy and individual and societal gain for Ireland. It will also assure the development and retention of the brightest research capacity and capability in the country."  

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing